These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33299257)

  • 1. Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity.
    Quy AS; Li X; Male L; Stankovic T; Agathanggelou A; Fossey JS
    Tetrahedron; 2020 Nov; 76(48):131631. PubMed ID: 33299257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia.
    Li X; Payne DT; Ampolu B; Bland N; Brown JT; Dutton MJ; Fitton CA; Gulliver A; Hale L; Hamza D; Jones G; Lane R; Leach AG; Male L; Merisor EG; Morton MJ; Quy AS; Roberts R; Scarll R; Schulz-Utermoehl T; Stankovic T; Stevenson B; Fossey JS; Agathanggelou A
    Medchemcomm; 2019 Aug; 10(8):1379-1390. PubMed ID: 32952998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.
    Steele AJ; Jones DT; Ganeshaguru K; Duke VM; Yogashangary BC; North JM; Lowdell MW; Kottaridis PD; Mehta AB; Prentice AG; Hoffbrand AV; Wickremasinghe RG
    Leukemia; 2006 Jun; 20(6):1073-9. PubMed ID: 16628188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against
    Gioia B; Ruggieri F; Biela A; Landry V; Roussel P; Piveteau C; Leroux F; Hartkoorn RC; Willand N
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells.
    Watson C; Miller DA; Chin-Sinex H; Losch A; Hughes W; Sweeney C; Mendonca MS
    Radiat Res; 2009 Apr; 171(4):389-96. PubMed ID: 19397439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt's Lymphoma (BL).
    Byrne AJ; Bright SA; McKeown JP; Bergin A; Twamley B; McElligott AM; Noorani S; Kandwal S; Fayne D; O'Boyle NM; Williams DC; Meegan MJ
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
    Dai Y; Guzman ML; Chen S; Wang L; Yeung SK; Pei XY; Dent P; Jordan CT; Grant S
    Br J Haematol; 2010 Oct; 151(1):70-83. PubMed ID: 20701602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
    Howard DR; Munir T; McParland L; Rawstron AC; Chalmers A; Gregory WM; O'Dwyer JL; Smith A; Longo R; Varghese A; Smith A; Hillmen P
    Health Technol Assess; 2017 May; 21(28):1-374. PubMed ID: 28628003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents.
    Ding Y; Yang Z; Ge W; Kuang B; Xu J; Yang J; Chen Y; Zhang Q
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1376-1391. PubMed ID: 30208745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of dual-action parthenolide prodrugs as potent anticancer agents.
    Taleghani A; Nasseri MA; Iranshahi M
    Bioorg Chem; 2017 Apr; 71():128-134. PubMed ID: 28215600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
    Yang Z; Kuang B; Kang N; Ding Y; Ge W; Lian L; Gao Y; Wei Y; Chen Y; Zhang Q
    Eur J Med Chem; 2017 Feb; 127():296-304. PubMed ID: 28068601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia.
    Wu RP; Hayashi T; Cottam HB; Jin G; Yao S; Wu CC; Rosenbach MD; Corr M; Schwab RB; Carson DA
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7479-84. PubMed ID: 20368435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.
    Nakabayashi H; Shimizu K
    BMC Cancer; 2012 Oct; 12():453. PubMed ID: 23039130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents.
    Liu X; Wang X
    Chin J Nat Med; 2022 Nov; 20(11):814-829. PubMed ID: 36427916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells.
    Zhao X; Liu X; Su L
    J Exp Clin Cancer Res; 2014 Jan; 33(1):3. PubMed ID: 24387758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
    Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
    Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
    Kishida Y; Yoshikawa H; Myoui A
    Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells.
    Li S; Gao X; Wu X; Wu Z; Cheng L; Zhu L; Shen D; Tong X
    Acta Biochim Biophys Sin (Shanghai); 2015 May; 47(5):368-75. PubMed ID: 25841439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.
    Flores-Lopez G; Moreno-Lorenzana D; Ayala-Sanchez M; Aviles-Vazquez S; Torres-Martinez H; Crooks PA; Guzman ML; Mayani H; Chávez-González A
    J Cell Mol Med; 2018 Oct; 22(10):4899-4912. PubMed ID: 30079458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.